Five AI-enhanced clinical trial start-ups to watch in 2021
Five AI-Enhanced Start-ups to Watch in 2021 Artificial intelligence (AI) is increasingly being employed to improve the operational efficiency of…
Data
-
-
GDPR: The Implications for Clinical Development
For those based in Europe, the General Data Protection Regulation (GDPR) came into force across the European Union on May…
-
New Data Suggest HCV Remains a Problem in the US
New data from the Centers for Disease Control and Prevention (CDC)’s National Health and Nutrition Survey (NHANES) suggest that hepatitis…
-
Industry Viewpoints: The Challenges of Clinical Data Management
Sarah Fal: Who is involved in the clinical data management process? Kumar Komuravelli: In general, it tends to be clinical…
-
How Can Blockchain Disrupt the Pharma Industry?
In the last few years, blockchain and cryptocurrencies have been all the rage, particularly in the financial services industry. When…
-
Expert Insights: Moderna Therapeutics Barrels Ahead Towards Historic IPO
Since its launch in 2010, Moderna Therapeutics has become as famous for its valuation as it has for the secrecy…
-
Industry Viewpoints: Leveraging eSource in Data Management
With numerous technologies beginning to disrupt the ways in which data are collected and generated, Sarah Fal speaks to Terry…
-
Perfect Communication? That’s an Oxymoron!
Relationships in general are complicated and require constant massaging and manipulation. Anyone in clinical research, knows that the relationship between…
-
Enriched Evidence Generation: Linking Clinical Data, Registries and Patient-Reported Outcomes to Health Care Utilization
Real world data (RWD) are playing an increasing role in health care decisions. Combining various datasets provides complementary insights and…
-
Expert Insights: Another Failure for BACE1 Drugs Raises Questions about Alzheimer’s Disease Treatments
Johnson & Johnson’s Janssen division has decided to halt the Phase II–III EARLY clinical trial (NCT02569398) of its Alzheimer’s disease…
